The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestment Co. Regulatory News (INV)

Share Price Information for Investment Co. (INV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.00
Bid: 310.00
Ask: 328.00
Change: -1.00 (-0.31%)
Spread: 18.00 (5.806%)
Open: 320.00
High: 320.00
Low: 319.00
Prev. Close: 320.00
INV Live PriceLast checked at -
Investment Company is an Investment Trust

To provide shareholders with an attractive level of dividends coupled with capital growth over the long-term, through the investment in a portfolio of equities, preference shares, loan stocks, debentures and convertibles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

19 Feb 2019 07:00

RNS Number : 4046Q
Investment Company PLC
19 February 2019
 

THE INVESTMENT COMPANY PLC

 

SUMMARY OF RESULTS

 

 

At

31 December 2018

(unaudited)

At

30 June 2018

(audited)

 

 

Change

%

Equity shareholders' funds (£)

15,622,682

17,334,093

(9.87)

Number of ordinary shares in issue

4,772,049

4,772,049

-

Net asset value ("NAV") per ordinary share

327.38p

363.24p

(9.87)

Ordinary share price (mid)

295.00p

331.00p

(10.88)

Discount to NAV

9.89%

8.88%

 

 

 

 

6 months to

12 months to

31 December 2018

30 June 2018

(unaudited)

(audited)

Total return per ordinary share

(25.16)p

12.27p

Return after taxation per ordinary share

(25.16)p

25.69p

Dividends paid per ordinary share

10.70p

20.70p

 

INVESTMENT OBJECTIVE

 

The Company's investment objective is to provide shareholders with an attractive level of dividends coupled with capital growth over the long term through investment in a portfolio of equities, preference shares, loan stocks, debentures and convertibles.

 

CHAIRMAN'S STATEMENT

 

Half-Year to 31 December 2018

 

During the period under review the FTSE AllShare Index fell by 12.54%. The Company's NAV was down by 9.87% which can be analysed as follows:

 

 

Pence per share

%

Opening net assets

363.24

100.00

Investment income

7.95

2.19

Dividends paid

(10.70)

(2.95)

Expenses

(3.76)

(1.03)

Portfolio outturn

(29.35)

(8.08)

Closing net assets

327.38

(9.87)

 

The share price fell by 10.88% in the period.

 

There have been some significant changes during the six-month period under review. On 9 July 2018, changes to the Board were announced. Your new Board then reviewed the portfolio and the Company's dividend levels. Pursuant to this the Directors have reduced the level of dividends paid as a step towards ensuring that any dividend paid to shareholders is covered by the income produced by the assets, after allowing for the fixed costs in order to give the Company a chance to grow in size.

 

Likewise portfolio changes were instigated and the Investment Managers have been seeking investments likely to achieve a portfolio yield of approximately 5%.

 

Currently the Investment Manager's diligence in seeking value from the Company's historic portfolio holdings, and in actively managing the portfolio in equity stocks in support of the investment policy is bearing fruit. The Investment Manager's Review is set out in their report on page 5 and 6.

 

Shareholders will note that the financial statements have been restated in accordance with the required transition to International Financial Reporting Standard 9 ("IFRS 9") Financial Instruments. Your attention is drawn to note 10 where further information is provided.

 

Your Board is conscious that the Company is still too small relative to its relatively fixed cost base and continues to seek out and evaluate opportunities that are likely to attract further capital and enhance shareholder returns.

 

I. R. Dighé

Chairman

18 February 2019

 

INVESTMENT MANAGER'S REPORT

 

Performance

During the period under review Brexit uncertainty has continued to dominate the headlines and investor sentiment as negotiations between the UK and EU progress. The US Dollar was stronger against Sterling whilst Sterling traded in a tight range with the Euro ending the period modestly down. Growth in the UK was surprisingly strong in the third quarter despite overall economic data trending lower. Weak house prices, falling car sales and anaemic retail data were all part of the picture of slowing growth.

 

The political uncertainty around Brexit has been damaging and has resulted in a wide degree of polarisation within the UK equity market. Companies with substantial overseas earnings have benefitted from the devaluation of sterling. In contrast UK domestic stocks have generally performed poorly and remain undervalued relative to the broader market. A smooth Brexit resolution is widely expected to result in an uplift in the share prices of many UK domestic facing stocks.

 

During the six month period to 31 December 2018 the NAV was down by 9.87% whilst the share price fell by 10.88%, which was ahead of major UK indices.

 

Portfolio

The largest corporate exposure in the portfolio is to Aggregated Micro Power Holdings ordinary shares where we have seen an uplift in value following the conversion of our holding in the 8% 2021 Convertible Loan Note. The Newcastle Building Society 3.886% 2019 is now the largest fixed interest holding in the Company. We expect this holding to be redeemed in December of this year.

 

We have initiated holdings in two housebuilders, Bovis and Persimmon, due to the attractive valuations offered alongside good dividend yields in excess of 8%. Both companies have significant and growing cash flows, large parts of which will be returned to shareholders. The housebuilding sector had a difficult 2018 however not enough housing is being built in the UK to meet current demand. In addition, Bovis continues to improve its build quality and reputation following the arrival of CEO, Greg Fitzgerald.

 

We purchased a holding in Greene King towards the end of the period as we believe the shares had been sold off too heavily due to pessimism over the UK leisure market. The shares were trading at a significant discount to the NAV, offered an attractive yield of over 6% and are supported by a progressive dividend policy. The shares have risen sharply following a strong Christmas trading update which saw £7.7m spent in their pubs on Christmas Day alone. The recent appointment of Nick Mackenzie, bodes well for the company with his extensive experience and track record in the leisure industry. He inherits a business in reasonable shape and can add his own vision and energy to drive top line sales whilst keeping costs under control.

 

GlaxoSmithKline continues to make progress under the relatively new CEO Emma Walmsley. In December the company announced it was spinning off its Consumer Healthcare business into a joint venture with Pfizer. Ultimately she is reinventing the company with large investments in R&D which we believe have the potential to deliver substantial benefits to patients and shareholders over the long term.

 

We have also been selectively adding to existing positions within the portfolio such as; Strix - kettle switch manufacturer, Phoenix Group Holdings - life insurance and pension's consolidator, ITV - TV broadcasting and production and Assura - UK REIT that builds and manages General Practitioner (GP) centres.

 

In the fixed interest part of the portfolio we have added a number of new names including Premier Oil 6.5% 2021 and EI Group - formerly Enterprise Inns - 7.5% 2024. The Premier Oil bond is the result of a major restructuring of the company's debt following the severe fall in the crude oil price during 2015/6. The company is now benefitting from an improved production schedule and generally higher oil prices, so much so that the overall debt burden is now falling. EI Group is performing very well in restructuring its business, paying down outstanding debts and improving the shape of its balance sheet. It recently announced a large disposal of pubs for an attractive price which will allow for a further reduction in outstanding debt in the company.

 

Prospects & Outlook

 

It is always a concern when markets fall sharply and in a very short space of time. Putting the recent falls into perspective, it comes after a benign period of positive equity market returns. We are now experiencing much more volatility as investors wrestle with political, economic and financial uncertainties particularly the impact of quantitative tightening by central banks after a prolonged period of fiscal largesse. A correction after a long bull run is not an unusual occurrence and history shows that periods of weakness tend to represent long-term buying opportunities. There have also been some very encouraging dividend increases which can be hidden by share price movements.

 

The backdrop to equity markets has positive elements. World economic growth although slowing is not plunging into recessionary territory, interest rates are rising but at a very slow pace and inflation appears to be under control. Indeed, recent economic indicators showing a deceleration in growth rates, has resulted in the Federal Reserve Bank putting any further potential interest rates rises on hold. There has been overvaluation of certain technology stocks in the US which is now unwinding but generally valuations are not over-stretched. Brexit issues are probably already priced into UK domestic shares which look cheap and could stage a relief rally irrespective of whether a hard or soft exit eventually occurs. It is impossible to predict the direction of bond and equity markets but we are comfortable with the long-term prospects of the high quality, diversified and robust companies that make up the portfolio.

 

M. Foster, J. P. Q. Harrison and J. Dieppe

Fiske plc

18 February 2019

 

TWENTY LARGEST INVESTMENTS

At 31 December 2018

 

Stock

Number

Book Cost £

Market Valuation £

% of total portfolio

1

Aggregated Micro Power

Ordinary 0.5p

714,286

500,000

642,857

4.69

2

Newcastle Building Society

3.849% sub notes 23/12/19

600,000

405,438

591,822

4.32

3

600 Group

8% conv loan notes 14/02/20

500,000

500,000

524,120

3.82

4

The Fishguard & Rosslare Railways and Harbours Company

3.50 % guaranteed preference stock

790,999

441,810

498,329

3.64

5

Intercede Group

8% conv loan notes 29/12/21

450,000

450,000

450,000

3.28

6

Nationwide Building Society

10.25% core capital deferred shares (variable)

3,100

490,536

432,937

3.16

7

National Westminster Bank

9% SER 'A' Non-Cum Preference

300,000

217,752

408,000

2.98

8

EI Group Plc

7.5% 15/03/24

400,000

409,099

398,718

2.91

9

Amalgamated Metals

5.4% Cum Pref £1

6% Cum Pref £1

256,065

213,510

144,049

103,844

204,852

192,159

 

 

 

 

247,893

397,011

2.90

10

Phoenix Group Holdings Ordinary Ordinary 10p *

69,445

452,745

390,975

2.85

11

National Grid

Ordinary 11.395p *

50,400

403,032

385,157

2.81

12

Vodafone Group

Ordinary $0.2095 *

242,002

501,387

370,018

2.70

13

Severn Trent

Ordinary 97.89p *

20,000

399,179

362,800

2.65

14

Renold

6% Cum Preference Stock

422,109

330,490

354,572

2.59

15

GlaxoSmithKline

Ordinary 25p *

23,050

324,891

343,722

2.51

16

Randall & Quilter Investment Holdings

Ordinary 2p*

201,884

194,445

329,071

2.40

17

Croda International

Ordinary 10.35p

5.9% Cum Preference

6,200

30,498

276,160

23,629

290,470

29,888

 

 

 

 

299,789

320,358

2.34

18

Premier Oil

6.5% Notes 31/05/21

310,000

300,097

291,443

2.13

19

Bristol Waterworks

4% Perpetual Debenture

360,118

209,705

288,094

2.10

20

Unilever PLC

Ordinary 3.11p *

7,000

272,063

287,595

2.10

 

 

 

7,350,351

8,067,599

58.88

* Issues with unrestricted voting rights

The Group has a total of 72 portfolio investment holdings in 58 companies.

 

INTERIM MANAGEMENT REPORT AND DIRECTORS' RESPONSIBILITY STATEMENT

 

Interim Management Report

 

The important events that have occurred during the period under review, the key factors influencing the financial statements and the principal risks and uncertainties for the remaining six months of the financial year are set out in the Chairman's Statement on page 4 and the Investment Manager's Report on pages 5 and 6.

 

The principal risks facing the Group are substantially unchanged since the date of the Report and Accounts for the year ended 30 June 2018 and continue to be as set out in that report. Risks faced by the Group include, but are not limited to, market risk (which comprises market price risk, interest rate risk, liquidity risk, and credit and counterparty risk). Details of the Company's management of these risks and exposure to them is set out in the Company's Report and Accounts for the year ended 30 June 2018.

 

There have been no significant changes in the related party disclosures set out in the Annual Report.

 

Responsibility Statement

The Directors confirm that to the best of their knowledge:

 

the condensed set of financial statements has been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, as adopted by the European Union; and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Group; and

 

this Half-Yearly Financial Report includes a fair review of the information required by:

 

a) DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

b) DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Group during that period; and any changes in the related party transactions that could do so.

 

This Half-Yearly Financial Report was approved by the Board of Directors on 18 February 2019 and the above responsibility statement was signed on its behalf by I. R. Dighé, Chairman.

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 31 December 2018

 

 

6 months to 31 December 2018

(unaudited)

6 months to 31 December 2017

(unaudited) restated

Year ended 30 June 2018

(unaudited) restated

 

Notes

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

 

£

£

£

£

£

£

£

£

£

Realised gains on investments

 

-

330,847

330,847

-

294,710

294,710

-

79,185

79,185

Unrealised (losses)/gains on investments held at fair value through profit or loss

 

-

(1,730,156)

(1,730,156)

 

17,652

17,652

-

88,161

88,161

Exchange losses on capital items

 

-

(58)

(58)

 

(862)

(862)

-

(3,050)

(3,050)

Unrealised losses on derivative financial instruments

 

-

-

-

 

(59,770)

(59,770)

-

(63,640)

(63,640)

Investment income

2

379,490

-

379,490

403,632

-

403,632

956,273

-

956,273

Investment management fee

 

(45,000)

-

(45,000)

(45,007)

-

(45,007)

(88,259)

-

(88,259)

Other expenses

 

(134,030)

(321)

(134,351)

(178,206)

-

(178,206)

(378,089)

(123)

(378,212)

Return before finance costs and taxation

 

200,460

(1,399,688)

(1,199,228)

180,419

251,730

432,149

489,925

100,533

590,458

Bank debit interest

 

-

-

-

-

-

-

-

-

-

Return before taxation

 

200,460

(1,399,688)

(1,199,228)

180,419

251,730

432,149

489,925

100,533

590,458

Taxation

 

(1,574)

-

(1,574)

(3,693)

-

(3,693)

(5,329)

-

(5,329)

Total comprehensive income after taxation

 

198,886

(1,399,688)

(1,200,802)

176,726

251,730

428,456

484,596

100,533

585,129

Return on total comprehensive income per 50p ordinary share

 

 

 

 

 

 

 

 

 

 

Basic and diluted

3

4.17

(29.33)

(25.16)

3.70

5.28

 8.98

 10.15

 2.11

 12.27

 

 

 

 

 

 

 

 

 

 

 

The total column of this statement is the Consolidated Statement of Total Comprehensive Income of the Group prepared in accordance with International Financial Reporting Standards ("IFRS").The supplementary revenue and capital columns are prepared in accordance with the Statement of Recommended Practice issued by the Association of Investment Companies ("AIC SORP").

 

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued during the period.

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 31 December 2018

 

 

Ordinary share capital

Share premium

Capital Redemption reserve

Revaluation reserve

Capital reserve

Revenue account

Total

 

£

£

£

£

£

£

£

Balance at 1 July 2018

2,386,025

4,453,903

2,408,820

2,557,941

6,669,594

(1,142,190)

17,334,093

Total comprehensive income

 

 

 

 

 

 

 

Net return for the period

-

-

-

-

(1,399,688)

198,886

(1,200,802)

Transactions with shareholders recorded directly to equity

 

 

 

 

 

 

 

Ordinary dividends paid

-

-

-

-

-

(510,609)

(510,609)

Balance at 31 December 2018

2,386,025

4,453,903

2,408,820

2,557,941

5,269,906

(1,453,913)

15,622,682

 

 

 

 

 

 

 

 

Balance at 1 July 2017 (restated)

2,386,025

4,453,903

2,408,820

2,557,941

6,569,061

(638,973)

17,736,777

Total comprehensive income

 

 

 

 

 

 

 

Net return for the period

-

-

-

-

251,730

176,726 

428,456 

Transactions with shareholders recorded directly to equity

 

 

 

 

 

 

 

Ordinary dividends paid

-

-

-

-

-

(510,609)

(510,609)

Balance at 31 December 2017

2,386,025

4,453,903

2,408,820

2,557,941

6,820,791

(972,856)

17,654,624

 

 

 

 

 

 

 

 

Balance at 1 July 2017 (restated)

2,386,025

4,453,903

2,408,820

2,557,941

6,569,061

(638,973)

17,736,777

Total comprehensive income

 

 

 

 

 

 

 

Net return for the year

-

-

-

-

100,533

484,596

585,129

Transactions with shareholders recorded directly to equity

 

 

 

 

 

 

 

Ordinary dividends paid

-

-

-

-

-

(987,813)

(987,813)

Balance at 30 June 2018

2,386,025

4,453,903

2,408,820

2,557,941

6,669,594

(1,142,190)

17,334,093

CONDENSED CONSOLIDATED BALANCE SHEET

As at 31 December 2018

 

 

Notes

31 December 2018 (unaudited)

31 December 2017

(unaudited)

(restated)

30 June 2018

(unaudited) (restated)

 

 

£

£

£

Non-current assets

 

 

 

 

Investments

 

13,709,874

16,066,412

16,342,406

 

 

 

 

 

Current assets

 

 

 

 

Derivative financial instruments

 

-

3,870

 -

Trade and other receivables

 

169,936

479,302

265,341

Cash and bank balances

 

1,826,565

1,184,295

843,433

 

 

1,996,501

1,667,467

1,108,774

Current liabilities

 

 

 

 

Trade and other payables

 

(83,693)

(79,255)

(117,087)

Net current assets

 

1,912,808

1,588,212

991,687

 

 

 

 

 

Net assets

 

15,622,682

17,654,624

17,334,093

 

 

 

 

 

Capital and reserves

 

 

 

 

Issued ordinary share capital

5

2,386,025

2,386,025

2,386,025

Share premium

 

4,453,903

4,453,903

4,453,903

Capital redemption reserve

 

2,408,820

2,408,820

2,408,820

Revaluation reserve

 

2,557,941

2,557,941

2,557,941

Capital reserve

 

5,269,906

6,820,791

6,669,594

Revenue reserve

 

(1,453,913)

(972,856)

(1,142,190)

Shareholders' funds

 

15,622,682

17,654,624

17,334,093

 

 

 

 

 

NAV per 50p ordinary share

6

 327.38

 369.96

 363.24

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

For the six months ended 31 December 2018

 

 

31 December 2018 (unaudited)

31 December 2017 (unaudited)

30 June

2018

(audited)

 

£

£

£

Cash flows from operating activities

 

 

 

Cash received from investments

335,085

449,975

920,760

Interest received

119,846

84

86

Sundry income

-

-

1,300

Investment management fees paid

(45,000)

(28,513)

(88,043)

Cash paid to and on behalf of employees

(1,167)

(7,280)

(14,000)

Other cash payments

(146,137)

(205,757)

(369,197)

Tax recoverable

(1,919)

-

-

Net cash inflow from operating activities

260,708

208,509

450,906

Cash flows from financing activities

 

 

 

Dividends paid on ordinary shares

(510,609)

(510,609)

(987,813)

Net cash outflow from financing activities

(510,609)

(510,609)

(987,813)

Cash flows from investing activities

 

 

 

Purchase of investments

(2,321,667)

(353,178)

(5,655,702)

Sale of investments

3,554,758

573,191

5,771,848

Purchase of derivative financial instruments

-

-

-

Net cash inflow from investing activities

1,233,091

220,013

116,146

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

983,190

(82,087)

(420,761)

Reconciliation of net cash flow to movement in net cash

 

 

 

Increase/(decrease) in cash

983,190

(82,087)

(420,761)

Exchange rate movements

(58)

(862)

(3,050)

Increase/(decrease) in net cash

983,132

(82,949)

(423,811)

Net cash at start of period

843,433

1,267,244

1,267,244

Net cash at end of period

1,826,565

1,184,295

843,433

 

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Significant accounting policies

 

Basis of preparation

The condensed consolidated financial statements, which comprise the unaudited results of the Company and its wholly owned subsidiaries, Abport Limited and New Centurion Trust Limited, together referred to as the "Group", have been prepared in accordance with IFRS, as adopted by the European Union, and as applied in accordance with the provisions of the Companies Act 2006. The financial statements have been prepared in accordance with the AIC SORP, except to any extent where it is not consistent with the requirements of IFRS. The accounting policies are as set out in the Report and Accounts for the year ended 30 June 2018.

 

The half-year financial statements have been prepared in accordance with IAS 34 "Interim Financial Reporting".

 

The financial information contained in this half year financial report does not constitute statutory accounts as defined by the Companies Act 2006.The financial information for the periods ended 31 December 2018 and 31 December 2017 have not been audited or reviewed by the Company's Auditor. The figures and financial information for the year ended 30 June 2018 are an extract from the latest published audited statements, as restated pursuant to the transition to IFRS 9, and do not constitute the statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and include a report of the Auditor, which was unqualified and did not contain a statement under either Section 498(2) or 498(3) of the Companies Act 2006.

 

Going concern

The Directors have made an assessment of the Group's ability to continue as a going concern and are satisfied that the Group has adequate resources to continue in operational existence for the foreseeable future (being a period of 12 months from the date these financial statements were approved). Furthermore, the Directors are not aware of any material uncertainties that may cast significant doubt upon the Group's ability to continue as a going concern, having taken into account the liquidity of the Group's investment portfolio and the Group's financial position in respect of its cash flows, borrowing facilities and investment commitments (of which there are none of significance).Therefore, the financial statements have been prepared on the going concern basis and on the basis that approval as an investment trust will continue to be met.

 

2. Income

 

31 December 2018 (unaudited)

31 December 2017

(unaudited)

30 June 2018

(audited)

 

£

£

£

Income from investments

 

 

 

UK dividends

236,944

154,586

505,852

Un-franked dividend income

25,583

59,023

96,066

UK Fixed interest

117,094

185,931

346,877

 

379,621

399,540

948,795

Other income

 

 

 

Bank deposit interest

-

84

85

Underwriting commission

-

-

1,300

Net dealing gains of subsidiaries

(131)

4,008

6,093

Total income

379,490

403,632

956,273

 

3. Return per ordinary share

Returns per share are based on the weighted average number of shares in issue during the period. Normal and diluted return per share are the same as there are no dilutive elements on share capital.

 

 

6 months to

31 December 2018

(unaudited)

6 months to

31 December 2017

(unaudited) (restated)

Year ended

30 June 2018

(audited)

 

Net return £

Per share pence

Net return £

Per share pence

Net return £

Per share pence

Return on total comprehensive income

 

 

 

 

 

 

Revenue

198,886

4.17

176,726

3.70

484,596

10.16

Capital

(1,399,688)

(29.33)

251,730

5.28

100,533

2.11

Total comprehensive income

(1,200,802)

(25.16)

428,456

8.98

585,129

12.27

 

 

 

 

 

 

 

Weighted average number of ordinary shares

 

4,772,049

 

4,772,049

 

4,772,049

 

4. Dividends per ordinary share

Amounts recognised as distributions to equity holders in the period.

 

 

6 months to 31 December 2018

(unaudited)

6 months to 31 December 2017

(unaudited)

Year ended 30 June 2018 (audited)

 

£

£

£

Ordinary shares

 

 

 

Prior year fourth interim dividend of 5.70p paid on 18 August 2017

-

272,007

272,007

Prior year first interim dividend of 5.70p paid on 17 November 2017

-

238,602

238,602

Prior year second interim dividend of 5.00p paid on 16 February 2018

-

-

238,602

Prior year third interim dividend of 5.00p paid on 25 May 2018

-

-

238,602

Prior year fourth interim dividend of 5.70p paid on 31 August 2018

272,007

-

-

Current year first interim dividend of 5.00p paid on 23 November 2018

238,602

-

-

Total income

510,609

510,609

987,813

 

The Board declared a second interim dividend of 3.75p per ordinary share, which was paid on 13 February 2019 to shareholders registered at the close of business on 11 January 2019. This dividend has not been included as a liability in these financial statements.

 

5. Ordinary share capital

 

 

6 months to

31 December 2018

(unaudited)

6 months to

31 December 2017

(unaudited)

Year ended

30 June 2018

(audited)

 

Number

£

Number

£

Number

£

 

Ordinary shares of 50p each

4,772,049

2,386,025

4,772,049

2,386,025

4,772,049

2,386,025

 

The Company does not hold any shares in treasury as at 31 December 2018 (31 December 2017: Nil and 30 June 2018: Nil).

 

6. Net asset value per ordinary share

Net asset value per ordinary share is based on net assets at the period end and 4,772,049 (31 December 2017: 4,772,049 and 30 June 2018: 4,772,049) ordinary shares in issue at the period end excluding shares held in treasury if any.

 

7. Investment Management fee

The management fee payable monthly in arrears by the Company to the Investment Manager, Fiske plc is calculated at the rate of one-twelfth of 0.75% per calendar month of the NAV of the Company, capped at £90,000 for the first twelve months. For these purposes, the NAV is calculated as at the last business day of each month.

 

At 31 December 2018 an amount of £7,500 (31 December 2017: £11,889 and 30 June 2018:

£7,500) was outstanding and due to the Investment Manager.

 

8. Fair value hierarchy

The fair value is the amount at which an asset could be sold in an ordinary transaction between market participants at the measurement date, other than a forced or liquidation sale. The Group measures fair values using the following hierarchy that reflects the significance of the inputs used in making the measurements.

 

Categorisation within the hierarchy has been determined on the basis of the lowest level input that is significant to the fair value measurement of the relevant asset as follows:

 

Level 1 - valued using quoted prices, unadjusted in active markets for identical assets and liabilities.

 

Level 2 - valued by reference to valuation techniques using observable inputs for the asset or liability other than quoted prices included in Level 1.

 

Level 3 - valued by reference to valuation techniques using inputs that are not based on observable market data for the asset or liability.

 

The table below sets out fair value measurement of financial instruments as at 31 December 2018, by the level in the fair value hierarchy into which the fair value measurement is categorised.

 

 

Level 1

Level 2

Level 3

Total

 

£

£

£

£

At 31 December 2018

 

 

 

 

Financial assets at fair value through profit and loss

9,327,357

310,136

4,072,381

13,709,874

Total

9,327,357

310,136

4,072,381

13,709,874

 

 

 

 

 

At 31 December 2017 (restated)

 

 

 

 

Fixed asset investments held by the Company

10,487,041

429,000

5,150,371

16,066,412

Derivative financial instruments

3,870

-

-

3,870

Total

10,490,911

429,000

5,150,371

16,070,282

 

 

 

 

 

At 30 June 2018

 

 

 

 

Fixed asset investments held by the Company

11,105,067

413,559

4,823,780

16,342,406

Total

11,105,067

413,559

4,823,780

16,342,406

 

The Company's subsidiary, Abport Limited, completes trading transactions. The value of the current asset investments held for trading is the expected price of realisation. The difference between the sale and purchase of assets is recognised as trading income in the Condensed Consolidated Statement of Comprehensive Income.

Reconciliation of Level 3 investments

The following table summarises Level 3 investments that were accounted for at fair value.

 

 

6 months ended 31 December 2018 (unaudited)

6 months ended 31 December 2017 (unaudited) (restated

Year ended

30 June 2018 (unaudited) (restated)

 

£

£

£

Opening balance

4,823,780

5,481,268

5,481,268

Movement in unrealised gains/(losses) on investments at fair value through profit or loss

228,596

(32,643)

(274,408)

Realised (losses)/gains

(306,957)

1,746

16,930

Sale proceeds

(673,038)

(300,000)

(400,010)

Closing balance

4,072,381

5,150,371

4,823,780

 

9. Transactions with the Investment Manager and related parties

As disclosed in note 7 a fee is paid to the Investment Manager in respect of its service provided to the Company.

 

10. Transition to IFRS 9 Financial Instruments

 

IFRS 9 'Financial Instruments' is effective for periods beginning on or after 1 January 2018 and has been adopted by the Group in the year. IFRS 9 sets out requirements for recognising and measuring financial assets and financial liabilities and replaces IAS 39 'Financial Instruments: Recognition and Measurement'. The impact on the consolidated financial statements of the Group is detailed below.

 

Classification of financial assets

IFRS 9 contains a new classification and measurement approach for financial assets that reflects the business model in which assets are managed and the cash flow characteristics of the assets.

 

IFRS 9 contains three principal classification categories for financial assets: measured at amortised cost, fair value through other comprehensive income and fair value through profit or loss. The standard eliminates the existing IAS 39 categories of held to maturity, loans and receivables and available for sale. The new classification requirements do impact the accounting for the Group's financial assets.

 

Impairment of financial assets

IFRS 9 replaces the incurred loss model in IAS 39 with a forward-looking 'expected credit loss' model. The new impairment model will apply to financial assets measured at amortised cost. There is no impact on the values reported in the financial statements from adopting IFRS 9 in respect of expected credit losses.

 

Cash and cash equivalents

Cash and cash equivalents are held at banks with a strong credit rating and are not subject to any period of notice. The Group typically maintains a low value of cash and cash equivalents. There is no impact on the values reported in the financial statements from adopting IFRS 9 in respect of expected credit losses.

 

Classification of financial liabilities

IFRS 9 largely retains the existing requirements in IAS 39 for the classification of financial liabilities. The classification requirements of IFRS 9 do not impact the financial statements.

 

Transition

The impact on the financial statements from the adoption of IFRS 9 is detailed below.

 

 

6 months to

31 December 2017

Year ended

30 June 2018

 

£

£

Consolidated statement of comprehensive income

 

 

Unrealised (losses)/gains on investments held at fair value through profit or loss

7,898

(644,268)

Movement in impairment provision on investments held as available for sale

(14,295)

3,745

 

(6,397)

(640,523)

Other comprehensive income

 

 

Movement in unrealised appreciation on investments held as available for sale

 

 

Recognised as equity

(342,148)

(30,134)

Recognised in return after taxation

348,545

670,657

 

6,397

640,523

 

-

Opening Reserves Adjustment

 

 

 

6 months to

31 December 2017

Year ended 30 June

2018

 

£

 £

Consolidated Balance Sheet and Consolidated Statement of Changes in Equity

 

 

 

 

Capital and reserves

 

 

Revaluation Reserve

6,397

640,523

Capital Reserve

(6,397)

(640,523)

 

-

-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR SFDFMAFUSELE
Date   Source Headline
29th Apr 20244:56 pmRNSNet Asset Value(s)
22nd Apr 20245:26 pmRNSNet Asset Value(s)
15th Apr 20244:57 pmRNSNet Asset Value(s)
9th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 20241:29 pmRNSNet Asset Value(s)
25th Mar 20243:37 pmRNSNet Asset Value(s)
19th Mar 20243:33 pmRNSNet Asset Value(s)
12th Mar 20249:58 amRNSNet Asset Value(s)
5th Mar 20242:56 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSHalf-year Report
27th Feb 202412:54 pmRNSNet Asset Value(s)
19th Feb 20244:00 pmRNSNet Asset Value(s)
15th Feb 20244:24 pmRNSDirector Declaration
6th Feb 20241:34 pmRNSNet Asset Value(s)
29th Jan 202410:24 amRNSNet Asset Value(s)
22nd Jan 20245:38 pmRNSNet Asset Value(s)
16th Jan 202410:39 amRNSNet Asset Value(s)
9th Jan 20241:55 pmRNSNet Asset Value(s)
4th Jan 202411:45 amRNSNet Asset Value(s)
27th Dec 20232:08 pmRNSNet Asset Value(s)
18th Dec 20232:11 pmRNSNet Asset Value(s)
12th Dec 20239:32 amRNSNet Asset Value(s)
4th Dec 20231:20 pmRNSNet Asset Value(s)
27th Nov 20233:48 pmRNSNet Asset Value(s)
20th Nov 20233:24 pmRNSNet Asset Value(s)
13th Nov 202310:07 amRNSNet Asset Value(s)
10th Nov 202311:04 amRNSDirector/PDMR Shareholding
9th Nov 202312:07 pmRNSDirector/PDMR Shareholding
7th Nov 202312:03 pmRNSResult of AGM
2nd Nov 20235:04 pmRNSNet Asset Value(s)
31st Oct 20235:06 pmRNSNet Asset Value(s)
23rd Oct 20233:29 pmRNSNet Asset Value(s)
16th Oct 20235:11 pmRNSNet Asset Value(s)
9th Oct 20233:34 pmRNSNet Asset Value(s) - Amendment
9th Oct 20233:19 pmRNSNet Asset Value(s)
6th Oct 202312:02 pmRNSNet Asset Value(s)
4th Oct 20233:22 pmRNSFinal Results
25th Sep 20234:52 pmRNSNet Asset Value(s)
20th Sep 202310:47 amRNSNet Asset Value(s)
11th Sep 20234:40 pmRNSNet Asset Value(s)
9th Aug 20232:04 pmRNSNet Asset Value(s)
9th Aug 202311:24 amRNSHolding(s) in Company
8th Aug 20234:13 pmRNSHolding(s) in Company
1st Aug 202311:09 amRNSTotal Voting Rights
27th Jul 20234:11 pmRNSHolding(s) in Company
27th Jul 20232:36 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSAdmission, Director Dealings & Total Voting Rights
19th Jul 20237:00 amRNSCalculation of the Tender Price and Issue Price
18th Jul 20237:00 amRNSResult of Tender Offer and Issue
26th Jun 20233:55 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.